Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats

Food and Chemical Toxicology

Volumn 49, Issue 10, 2011, Pages 2631-2637

  Pérez Rojas, Jazmin M ^a,b   Guerrero Beltrán, Carlos Enrique ^a   Cruz, Cristino ^c   Sánchez González, Dolores J ^d   Martínez Martínez, Claudia M ^d   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d Universidad del Ejercito y Fuerza Aerea   (Mexico)

Author keywords

Cisplatin; Kidney damage; Oxidative stress; Tert Butylhydroquinone

Indexed keywords

CISPLATIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; TERT BUTYLHYDROQUINONE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; NEPHROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROQUINONES; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 80051905926     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.008     Document Type: Article

References (33)

1. Ali B.H., Al Moundhri M.S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. 2006, 44:1173-1183.
2. Guerrero-Beltrán C.E., Calderón-Oliver M., Tapia E., Medina-Campos O.N., Sánchez-González D.J., Martínez-Martínez C.M., Ortiz-Vega K.M., Franco M., Pedraza-Chaverri J. Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol Lett. 2010, 192:278-285.
3. Chirino Y.I., Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 2009, 61:223-242.
4. Chirino Y.I., Sánchez-González D.J., Martínez-Martínez C.M., Cruz C., Pedraza-Chaverri J. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008, 12:18-23.
5. Chirino Y.I., Hernandez-Pando R., Pedraza-Chaverri J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin induced nephrotoxicity in rats. BMC Pharmacol. 2004, 4:20.
6. Chirino Y.I., Trujillo J., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., Bobadilla N.A., Pedraza-Chaverri J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol. Lett. 2008, 176:48-57.
7. Dinkova-Kostova A.T., Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol. Nutr. Food Res. 2008, 52(Suppl. 1):S128-S138.
8. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 1991, 266:4556-4561.
9. Fontanelli R., Spatti G., Raspagliesi F., Zunino F., Di Re F. A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann. Oncol. 1992, 3:1121-1171.
10. Francescato H.D., Costa R.S., Scavone C., Coimbra T.M. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007, 230:64-75.
11. Food and Agriculture Organization of the United Nations/World Health Organization, 1999. Evaluation of Certain Food Additives and Contaminants (49th Report of the Joint FAO/WHO Expert Committee on Food Additives). World Health Organ. Tech. Rep. Ser. 884, i-viii, 1-96.
12. Gandara D.R., Perez E.A., Weibe V., De Gregório M.W. Cisplatin chemoprotection and rescue: pharmacological modulation of toxicity. Semin. Oncol. 1991, 18:49-55.
13. Gerard-Monnier D., Erdelmeier I., Regnard K., Moze-Henry N., Yadan J.C., Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 1998, 11:1176-1183.
14. Hara H., Ohta M., Ohta K., Kuno S., Adachi T. Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Brain Res. Mol. Brain Res. 2003, 119:125-131.
15. Ikeda G.J., Sapienza P.P., Ross I.A. Distribution and excretion of radiolabelled tert-butylhydroquinone in Fischer 344 rats. Food Chem. Toxicol. 1998, 36:907-914.
16. Khan S.A., Priyamvada S., Khan W., Khan S., Farooq N., Yusufi A.N. Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol. Res. 2009, 60:382-391.
17. Kim J.I., Lee J.H., Choi D.S., Won B.M., Jung M.Y., Park J. Kinetic study of the quenching reaction of singlet oxygen by common synthetic antioxidants (tert-butylhydroxyanisol, tert-di-butylhydroxytoluene, and tert-butylhydroquinone) as compared with alpha-tocopherol. J. Food Sci. 2009, 74:C362-C369.
18. Kraft A.D., Johnson D.A., Johnson J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 2004, 24:1101-1112.
19. Koh K., Cha Y., Kim S., Kim J. TBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation. Biochem. Biophys. Res. Commun. 2009, 380:449-453.
20. Lavoie S., Chen Y., Dalton T.P., Gysin R., Cuénod M., Steullet P., Do K.Q. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J. Neurochem. 2009, 108:1410-1422.
21. Loehrer P.J., Einhorn L.H. Drug five years later. Cisplatin. Ann. Int. Med. 1984, 100:704-713.
22. Maldonado P.D., Barrera D., Rivero I., Mata R., Medina-Campos O.N., Hernandez-Pando R., Pedraza-Chaverrí J. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic. Biol. Med. 2003, 35:317-324.
23. Ozols R.F. Current status of chemotherapy for ovarian cancer. Semin. Oncol. 1995, 22:61-66.
24. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms renoprotective strategies. Kidney Int. 2008, 73:994-1007.
25. Panici P.B., Greggi S., Scambia G., Ragusa G., Baiocchi G., Battaglia F., Coronetta F., Mancuso S. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol. Oncol. 1991, 41:212-216.
26. Pérez-Rojas J.M., Cruz C., García-López P., Sánchez-González D.J., Martínez-Martínez C.M., Ceballos G., Espinosa M., Meléndez-Zajgla J., Pedraza-Chaverri J. Renoprotection by α-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic. Res. 2009, 43:1122-1132.
27. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 1990, 265:14648-14653.
28. Tasset I., Pérez-De La Cruz V., Elinos-Calderón D., Carrillo-Mora P., González-Herrera I.G., Luna-López A., Konigsberg M., Pedraza-Chaverrí J., Maldonado P.D., Ali S.F., Túnez I., Santamaría A. Protective effect of tert-butylhydroquinone on the quinolinic-acid-Induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway. Neurosignals 2010, 18:24-31.
29. Townsend D.M., Deng M., Zhang L., Lapus M.G., Hanigan M.H. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J. Am. Soc. Nephrol. 2003, 14:1-10.
30. Wang J., He D., Zhang Q., Han Y., Jin S., Qi F. Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother. Radiopharm. 2009, 24:675-680.
31. Wang X., Au-Yeung S.C., Ho Y.P. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats. J. Inorg. Biochem. 2007, 101:909-917.
32. Yao X., Panichpisal K., Kurtzman N., Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007, 334:115-124.
33. Yousef M.I., Saad A.A., El-Shennawy L.K. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem. Toxicol. 2009, 47:1176-1183.